Titan Pharmaceuticals (TTNP) Competitors $4.40 +0.05 (+1.15%) As of 03:53 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock TTNP vs. PMN, GOVX, PRPH, ALLR, HOTH, LEXX, NKGN, CASI, SYBX, and EDSAShould you be buying Titan Pharmaceuticals stock or one of its competitors? The main competitors of Titan Pharmaceuticals include Promis Neurosciences (PMN), GeoVax Labs (GOVX), ProPhase Labs (PRPH), Allarity Therapeutics (ALLR), Hoth Therapeutics (HOTH), Lexaria Bioscience (LEXX), NKGen Biotech (NKGN), CASI Pharmaceuticals (CASI), Synlogic (SYBX), and Edesa Biotech (EDSA). These companies are all part of the "pharmaceutical products" industry. Titan Pharmaceuticals vs. Its Competitors Promis Neurosciences GeoVax Labs ProPhase Labs Allarity Therapeutics Hoth Therapeutics Lexaria Bioscience NKGen Biotech CASI Pharmaceuticals Synlogic Edesa Biotech Titan Pharmaceuticals (NASDAQ:TTNP) and Promis Neurosciences (NASDAQ:PMN) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, dividends, valuation and earnings. Do analysts prefer TTNP or PMN? Promis Neurosciences has a consensus target price of $4.50, indicating a potential upside of 871.92%. Given Promis Neurosciences' stronger consensus rating and higher probable upside, analysts clearly believe Promis Neurosciences is more favorable than Titan Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Titan Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Promis Neurosciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to TTNP or PMN? In the previous week, Titan Pharmaceuticals had 5 more articles in the media than Promis Neurosciences. MarketBeat recorded 5 mentions for Titan Pharmaceuticals and 0 mentions for Promis Neurosciences. Titan Pharmaceuticals' average media sentiment score of 0.45 beat Promis Neurosciences' score of 0.00 indicating that Titan Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Titan Pharmaceuticals Neutral Promis Neurosciences Neutral Do institutionals and insiders believe in TTNP or PMN? 31.5% of Titan Pharmaceuticals shares are owned by institutional investors. Comparatively, 50.1% of Promis Neurosciences shares are owned by institutional investors. 0.7% of Titan Pharmaceuticals shares are owned by insiders. Comparatively, 6.1% of Promis Neurosciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has higher earnings and valuation, TTNP or PMN? Promis Neurosciences has lower revenue, but higher earnings than Titan Pharmaceuticals. Promis Neurosciences is trading at a lower price-to-earnings ratio than Titan Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTitan Pharmaceuticals$180K22.24-$4.71M-$4.59-0.96Promis NeurosciencesN/AN/A$2.78M-$0.05-9.26 Which has more volatility and risk, TTNP or PMN? Titan Pharmaceuticals has a beta of 1.27, meaning that its share price is 27% more volatile than the S&P 500. Comparatively, Promis Neurosciences has a beta of -0.1, meaning that its share price is 110% less volatile than the S&P 500. Is TTNP or PMN more profitable? Titan Pharmaceuticals' return on equity of -145.92% beat Promis Neurosciences' return on equity.Company Net Margins Return on Equity Return on Assets Titan PharmaceuticalsN/A -145.92% -129.20% Promis Neurosciences N/A -186.19%-98.56% SummaryPromis Neurosciences beats Titan Pharmaceuticals on 8 of the 14 factors compared between the two stocks. Get Titan Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TTNP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TTNP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TTNP vs. The Competition Export to ExcelMetricTitan PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.98M$2.91B$5.54B$8.95BDividend YieldN/A2.42%5.38%4.08%P/E Ratio-0.9621.4227.3820.03Price / Sales22.24285.81422.31120.16Price / CashN/A41.9536.6357.47Price / Book1.657.518.085.67Net Income-$4.71M-$55.05M$3.16B$248.47M7 Day Performance1.13%3.16%2.12%2.90%1 Month Performance-7.76%5.92%4.43%5.75%1 Year Performance-16.35%5.82%35.62%21.36% Titan Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TTNPTitan Pharmaceuticals0.3534 of 5 stars$4.40+1.1%N/A-18.0%$3.98M$180K-0.9610PMNPromis Neurosciences3.6626 of 5 stars$0.48+0.7%$4.50+830.1%-73.0%$15.70MN/A-9.685Gap UpGOVXGeoVax Labs3.3732 of 5 stars$0.87-9.8%$11.10+1,182.2%-85.6%$15.29M$3.95M-0.2410News CoverageGap UpPRPHProPhase Labs1.4738 of 5 stars$0.39+6.6%N/A-89.4%$15.25M$6.77M-0.31130ALLRAllarity Therapeutics1.1456 of 5 stars$1.01+1.0%N/A-84.6%$15.08MN/A0.0010News CoverageHOTHHoth Therapeutics1.5934 of 5 stars$1.17+3.5%$4.00+241.9%+35.9%$14.93MN/A-1.034Gap DownLEXXLexaria Bioscience3.061 of 5 stars$0.87+2.5%$7.00+704.6%-67.4%$14.91M$460K-1.477News CoverageAnalyst ForecastAnalyst RevisionNKGNNKGen BiotechN/A$0.33+37.4%N/A-75.2%$14.83MN/A-0.06N/ACASICASI Pharmaceuticals4.1375 of 5 stars$1.18-1.7%$4.00+239.0%-75.4%$14.76M$28.54M-0.46180News CoveragePositive NewsHigh Trading VolumeSYBXSynlogic0.5352 of 5 stars$1.27+2.4%N/A-15.7%$14.50M$10K-0.5180Gap UpEDSAEdesa Biotech1.7596 of 5 stars$2.03-1.0%$5.00+146.3%-51.5%$14.40MN/A-1.2820Positive News Related Companies and Tools Related Companies Promis Neurosciences Alternatives GeoVax Labs Alternatives ProPhase Labs Alternatives Allarity Therapeutics Alternatives Hoth Therapeutics Alternatives Lexaria Bioscience Alternatives NKGen Biotech Alternatives CASI Pharmaceuticals Alternatives Synlogic Alternatives Edesa Biotech Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TTNP) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Titan Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Titan Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
